Liminatus Pharma, Inc., a pre-clinical stage biopharmaceutical company, engages in the development of cancer therapies in the United States. It develops IBA101, a humanized anti CD47 monoclonal antibody, which is in Phase I clinical trial f...
Leadership
Chris Kim J.D., L.L.M.
CEO & Chairman
Scott Dam
Chief Financial Officer
Beom Kyu Choi
Chief Technology Officer & Member of Scientific Advisory Board
Byong Chul Yoo Ph.D.
Chief Science Officer & Member of Scientific Advisory Board
Sang-jin Lee Ph.D.
Head of Research & Development and Member of Scientific Advisory Board
